Basal Cell Skin Cancer, Version 2.2024

Chrysalyne D. Schmults; Rachel Blitzblau; Sumaira Z. Aasi; Murad Alam; Arya Amini; Kristin Bibee; Jeremy Bordeaux; Pei Ling Chen; Carlo M. Contreras; Dominick DiMaio; Jessica M. Donigan; Jeffrey M. Farma; Karthik Ghosh; Kelly Harms; Alan L. Ho; John Nicholas Lukens; Lawrence Mark; Theresa Medina; Kishwer S. Nehal; Paul Nghiem; Kelly Olino; Soo Park; Tejesh Patel; Igor Puzanov; Jason Rich; Aleksandar Sekulic; Ashok R. Shaha; Divya Srivastava; Valencia Thomas; Courtney Tomblinson; Puja Venkat; Yaohui Gloria Xu; Siegrid Yu; Mehran Yusuf; Beth McCullough; Sara Espinosa

doi:10.6004/jnccn.2023.0056

Basal Cell Skin Cancer, Version 2.2024

Chrysalyne D. Schmults
, Rachel Blitzblau
, Sumaira Z. Aasi
, Murad Alam
, Arya Amini
, Kristin Bibee
, Jeremy Bordeaux
, Pei Ling Chen
, Carlo M. Contreras
, Dominick DiMaio
, Jessica M. Donigan
, Jeffrey M. Farma
, Karthik Ghosh
, Kelly Harms
, Alan L. Ho
, John Nicholas Lukens
, Lawrence Mark
, Theresa Medina
, Kishwer S. Nehal
, Paul Nghiem

Kelly Olino, Soo Park, Tejesh Patel, Igor Puzanov, Jason Rich, Aleksandar Sekulic, Ashok R. Shaha, Divya Srivastava, Valencia Thomas, Courtney Tomblinson, Puja Venkat, Yaohui Gloria Xu, Siegrid Yu, Mehran Yusuf, Beth McCullough, Sara Espinosa

Medicine

Dana-Farber
Duke University
Stanford University
Northwestern University
City of Hope National Med Center
Johns Hopkins University
Case Western Reserve University
Moffitt Cancer Center
Ohio State University
University of Nebraska Medical Center
University of Utah
Fox Chase Cancer Center
Mayo Clinic Rochester, MN
University of Michigan, Ann Arbor
Memorial Sloan-Kettering Cancer Center
University of Pennsylvania
Indiana University Bloomington
University of Colorado Anschutz Medical Campus
Fred Hutchinson Cancer Research Center
Yale University
University of California at San Diego
University of Tennessee Health Science Center
Washington University St. Louis
UT Southwestern Simmons Comprehensive Cancer Center
University of Texas MD Anderson Cancer Center
Vanderbilt University
University of California at Los Angeles
University of Wisconsin-Madison
University of California at San Francisco
University of Alabama at Birmingham
National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

105 Scopus citations

Abstract

Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline an updated risk stratification and treatment options available for BCC.

Original language	English
Pages (from-to)	1181-1203
Number of pages	23
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	11
DOIs	https://doi.org/10.6004/jnccn.2023.0056
State	Published - 2023

Access to Document

10.6004/jnccn.2023.0056

Cite this

Schmults, C. D., Blitzblau, R., Aasi, S. Z., Alam, M., Amini, A., Bibee, K., Bordeaux, J., Chen, P. L., Contreras, C. M., DiMaio, D., Donigan, J. M., Farma, J. M., Ghosh, K., Harms, K., Ho, A. L., Lukens, J. N., Mark, L., Medina, T., Nehal, K. S., ... Espinosa, S. (2023). Basal Cell Skin Cancer, Version 2.2024. JNCCN Journal of the National Comprehensive Cancer Network, 21(11), 1181-1203. https://doi.org/10.6004/jnccn.2023.0056

@article{d1c43f0f86ce4ec1a0fb876a3bfcee7a,

title = "Basal Cell Skin Cancer, Version 2.2024",

abstract = "Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline an updated risk stratification and treatment options available for BCC.",

author = "Schmults, \{Chrysalyne D.\} and Rachel Blitzblau and Aasi, \{Sumaira Z.\} and Murad Alam and Arya Amini and Kristin Bibee and Jeremy Bordeaux and Chen, \{Pei Ling\} and Contreras, \{Carlo M.\} and Dominick DiMaio and Donigan, \{Jessica M.\} and Farma, \{Jeffrey M.\} and Karthik Ghosh and Kelly Harms and Ho, \{Alan L.\} and Lukens, \{John Nicholas\} and Lawrence Mark and Theresa Medina and Nehal, \{Kishwer S.\} and Paul Nghiem and Kelly Olino and Soo Park and Tejesh Patel and Igor Puzanov and Jason Rich and Aleksandar Sekulic and Shaha, \{Ashok R.\} and Divya Srivastava and Valencia Thomas and Courtney Tomblinson and Puja Venkat and Xu, \{Yaohui Gloria\} and Siegrid Yu and Mehran Yusuf and Beth McCullough and Sara Espinosa",

year = "2023",

doi = "10.6004/jnccn.2023.0056",

language = "English",

volume = "21",

pages = "1181--1203",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "11",

}

Schmults, CD, Blitzblau, R, Aasi, SZ, Alam, M, Amini, A, Bibee, K, Bordeaux, J, Chen, PL, Contreras, CM, DiMaio, D, Donigan, JM, Farma, JM, Ghosh, K, Harms, K, Ho, AL, Lukens, JN, Mark, L, Medina, T, Nehal, KS, Nghiem, P, Olino, K, Park, S, Patel, T, Puzanov, I, Rich, J, Sekulic, A, Shaha, AR, Srivastava, D, Thomas, V, Tomblinson, C, Venkat, P, Xu, YG, Yu, S, Yusuf, M, McCullough, B & Espinosa, S 2023, 'Basal Cell Skin Cancer, Version 2.2024', JNCCN Journal of the National Comprehensive Cancer Network, vol. 21, no. 11, pp. 1181-1203. https://doi.org/10.6004/jnccn.2023.0056

TY - JOUR

T1 - Basal Cell Skin Cancer, Version 2.2024

AU - Schmults, Chrysalyne D.

AU - Blitzblau, Rachel

AU - Aasi, Sumaira Z.

AU - Alam, Murad

AU - Amini, Arya

AU - Bibee, Kristin

AU - Bordeaux, Jeremy

AU - Chen, Pei Ling

AU - Contreras, Carlo M.

AU - DiMaio, Dominick

AU - Donigan, Jessica M.

AU - Farma, Jeffrey M.

AU - Ghosh, Karthik

AU - Harms, Kelly

AU - Ho, Alan L.

AU - Lukens, John Nicholas

AU - Mark, Lawrence

AU - Medina, Theresa

AU - Nehal, Kishwer S.

AU - Nghiem, Paul

AU - Olino, Kelly

AU - Park, Soo

AU - Patel, Tejesh

AU - Puzanov, Igor

AU - Rich, Jason

AU - Sekulic, Aleksandar

AU - Shaha, Ashok R.

AU - Srivastava, Divya

AU - Thomas, Valencia

AU - Tomblinson, Courtney

AU - Venkat, Puja

AU - Xu, Yaohui Gloria

AU - Yu, Siegrid

AU - Yusuf, Mehran

AU - McCullough, Beth

AU - Espinosa, Sara

PY - 2023

Y1 - 2023

N2 - Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline an updated risk stratification and treatment options available for BCC.

AB - Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline an updated risk stratification and treatment options available for BCC.

UR - https://www.scopus.com/pages/publications/85176764402

U2 - 10.6004/jnccn.2023.0056

DO - 10.6004/jnccn.2023.0056

M3 - Article

C2 - 37935106

AN - SCOPUS:85176764402

SN - 1540-1405

VL - 21

SP - 1181

EP - 1203

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 11

ER -

Basal Cell Skin Cancer, Version 2.2024

Abstract

Access to Document

Other files and links

Fingerprint

Cite this